Der Hautarzt (HAUTARZT)

Publisher: Deutsche Dermatologische Gesellschaft, Springer Verlag

Journal description

Der Hautarzt ist als Organ der Deutschen Dermatologischen Gesellschaft eine international angesehene Zeitschrift und informiert regelmäßig alle in Klinik und Praxis tätigen Dermatologen über wichtige Entwicklungen in der gesamten Dermatologie einschließlich Allergologie Venerologie und ihrer verwandten Gebiete. In Originalarbeiten werden wichtige klinisch relevante Studien und Forschungsergebnisse veröffentlicht. Kritisch und kompetent widmet sich der Aktuelle Kommentar einer im Brennpunkt stehenden Fragestellung. Die Übersicht führt den Leser in ein zentrales Thema seines klinischen Alltags ein und gibt den Überblick über den state of the art. In den Farbbildkasuistiken zeigen Fallbeispiele Wege der rationalen Diagnostik und Entscheidungsfindung. In der Rubrik Weiterbildung wird dem Assistenzarzt in Weiterbildung zum Facharzt didaktisch aufgearbeiteter Wissensstoff und dem Niedergelassenen ein optimiertes Repetitorium vermittelt. In den Gelben Seiten informiert die DDG regelmäßig über die Aktivitäten der Arbeitsgemeinschaften und des Vorstands Fakten zur Gesundheitspolitik und Kongreßaktivitäten. Die Anfragen aus der Praxis spiegeln den Dialog der Leser mit ihrer Facharztzeitschrift wider. In Gehört - Gelesen - Nachgefragt wird über aktuelle Themen von grundsätzlicher medizinischer bzw. interdisziplinärer Bedeutung berichtet. Zur Publikation eingereichte Manuskripte müssen bei Untersuchungen an Probanden oder Patienten die Erklärung enthalten daß das Versuchsprotokoll von einer Ethikkommission begutachtet wurde und somit den ethischen Standards der Deklaration von Helsinki 1964 in der jeweils gültigen Fassung (Pharm. Ind. Nr. 12/1990 sowie Bundesanzeiger Nr. 243a vom 29. 12. 1989) entspricht. Gleichzeitig ist - gegebenenfalls - die Einwilligung des Patienten nach Aufklärung im Text des Manuskriptes zu fixieren. Hinweise die auf die Identität schließen lassen sind zu vermeiden. Tierversuchsprogramme müssen den Passus enthalten daß die "Principles of laboratory animal care" (NIH publication No. 86-23 revised 1985) eingehalten wurden soweit nicht zusätzlich besondere nationale Regelungen zu beachten sind (für die Bundesrepublik Deutschland ist dies das Tierschutzgesetz in aktueller Fassung). Die Schriftleitung behält sich deshalb das Recht vor Manuskripte abzulehnen die den o.g. Anforderungen nicht entsprechen. Der Autor haftet bei Verstoß gegen die o.g. Anforderungen oder bei falschen Angaben.

Current impact factor: 0.56

Impact Factor Rankings

2016 Impact Factor Available summer 2017
2014 / 2015 Impact Factor 0.564
2013 Impact Factor 0.543
2012 Impact Factor 0.504
2011 Impact Factor 0.576
2010 Impact Factor 0.451
2009 Impact Factor 0.434
2008 Impact Factor 0.362
2007 Impact Factor 0.333
2006 Impact Factor 0.498
2005 Impact Factor 0.535
2004 Impact Factor 0.461
2003 Impact Factor 0.521
2002 Impact Factor 0.426
2001 Impact Factor 0.612
2000 Impact Factor 0.535
1999 Impact Factor 0.552
1998 Impact Factor 0.479
1997 Impact Factor 0.487
1996 Impact Factor 0.422
1995 Impact Factor 0.314
1994 Impact Factor 0.397
1993 Impact Factor 0.321
1992 Impact Factor 0.314

Impact factor over time

Impact factor
Year

Additional details

5-year impact 0.51
Cited half-life >10.0
Immediacy index 0.09
Eigenfactor 0.00
Article influence 0.11
Website Hautarzt, Der website
Other titles Hautarzt (Online)
ISSN 0017-8470
OCLC 42959962
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Springer Verlag

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Author's pre-print on pre-print servers such as arXiv.org
    • Author's post-print on author's personal website immediately
    • Author's post-print on any open access repository after 12 months after publication
    • Publisher's version/PDF cannot be used
    • Published source must be acknowledged
    • Must link to publisher version
    • Set phrase to accompany link to published version (see policy)
    • Articles in some journals can be made Open Access on payment of additional charge
  • Classification
    green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background One of the most significant, and growing, challenges in modern medicine, i.e. the treatment of chronic wounds, is marked by nonuniform data. This concerns both prevalence and incidence of chronic dermatosis, in particular venous ulcers (ulcus cruris), as well as the impact on the health-related quality of life, and practical and economic parameters of the success of different therapies. Purpose The aim of this work is to examine the epidemiology of chronic wounds, in particular age-associated venous ulcers, their impact on health-related quality of life, the treatment regimen, and practical and economic parameters of the success of different therapies. Materials and methods Performed were analysis of data on the care of venous ulcers in Germany, based on secondary data of Barmer GEK from 2009 and 2012, comparison with data of a NHS Kent Community Health Trust study, and analysis of studies concerning structures, processes and critical success factors for the treatment of chronic wounds, including economic effects. Conclusion Early causal therapy with treatment based on the stage of the wound, consequent goal-oriented interdisciplinary care, and relapse prophylaxis is critical for successful healing of venous ulcers. The costs of treatment significantly correlate with the duration of treatment which can be reduced by up to 60 % using guideline-based concepts for the treatment of chronic wounds. Treatment success, in particular with regard to cost–benefit considerations, can be optimized by telemedicine networks of key players who treat chronic wounds.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Tattoos are regarded as body jewelry and have become widespread in all parts of society. Despite introduction of the tattooing agents’ regulation (Tätowiermittelverordnung) in Germany in 2009, consumer protection is incomplete. Objectives Prevalence of tattoos and their legal basis, ingredients of tattooing agents, clinical findings of adverse reactions, pathogenesis and therapy. Methods The work is based on a selective literature search in PubMed and on the clinical experience of the authors. Results Adverse reactions by tattooing are a particular problem, because the causing substances are not biodegradable within the tissue. In addition to an agonizing pruritus, the clinical picture is characterized by erythematous plaques. Histopathology reveals different patterns of inflammation, including pseudolymphomatous reactions. Treatment is problematic. In many cases, extensive surgical excision is necessary, which is associated with cosmetic consequences. Conclusion A regulation to assess the safety of tattooing does not exist.
    No preview · Article · Jan 2016 · Der Hautarzt
  • Article: Vitiligo
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Vitiligo is a chronic skin disorder with depigmentation of circumscribed areas due to structural and functional damage to melanocytes. Results There is international consensus on the classification in nonsegmental and segmental vitiligo. The influence of vitiligo on the quality of life is significant and is influenced by ethnic and sociocultural factors. There is a new insight into the genetic susceptibility, mechanisms and targets of the autoimmune inflammation, the altered morphology and function of melanocytes and into the association of vitiligo with other autoimmune diseases, skin cancer and skin cancer therapy. Conclusions The recognition of associated autoimmune disorders is as important as is the assessment of changes in the quality of life. New insight into the pathogenesis may have therapeutic consequences. The relationship between vitiligo and skin cancer and between vitiligo and immunotherapies in patients with metastatic melanoma warrants close clinical monitoring of affected patients and further scientific studies.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Ultraviolet (UV) radiation of sunbeds has been classified carcinogenic by the International Agency for Research on Cancer (IARC). Unlike in other countries the available data on the important risk factor has been lacking until recently in Germany. Objectives The SUN-Study 2012 (Sunbed-Use: Needs for Action Study) aimed at identifying epidemiological prevalence data concerning this completely preventable risk factor. Materials and methods A total of 4,851 participants aged 14–45 years were selected from the German population in a representative manner and were surveyed via standardized telephone interviews. The survey period was split into a summer and a winter wave in order to take possible season effects into account. Results Four out of 10 Germans aged 14–45 years (39.2 %; 95 % CI 37.8–40.6 %) have ever used a sunbed. Within the last year 14.6 % (95 % CI 13.6–15.6 %) visited a sunbed. Current users reported six visits per year on average and every twentieth reported a family history of cutaneous malignant melanoma in first-degree relatives. More than 5 % of minors currently used sunbeds despite the nationwide ban, mostly at unsupervised locations. Half of those minors did not know about the legal ban of sunbed use for minors. Conclusions Our study proves that sunbed use which is an important risk factor for skin cancer is widely used. Moreover, considerable information deficits about health risks exist among the German population.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aging affects human skin and is becoming increasingly important with regard to medical, social and aesthetic issues. Detection of intrinsic and extrinsic components of skin aging requires reliable measurement methods. Modern techniques, e.g., based on direct imaging, spectroscopy or skin physiological measurements, provide a broad spectrum of parameters for different applications.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: The porphyrias comprise a clinically, biochemically, and genetically heterogeneous group of predominantly hereditary metabolic disorders resulting from a dysfunction along the heme biosynthetic pathway. Whereas most variants can manifest with different cutaneous symptoms, some types only reveal life-threatening acute neurovisceral attacks. Therefore, interdisciplinary care of these patients is advisable. In this article, we provide an overview of characteristic clinical and laboratory findings in the various forms of porphyria and a diagnostic algorithm.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Porphyria cutanea tara (PCT) has a prevelance of about 40 new diagnoses per 1 million people per year and is the most frequently occurring type of porphyria worldwide. Inhibition of the uroporphyrinogen decarboxylase (UROD) is the main cause of the disease, which can be the result of a heterozygous or homozygous mutation of the UROD gene; however, xenobiotics or other diseases may play an important role for the precipitation of the disease. Risk factors include alcohol, estrogen, iron overload, and hemochromatosis, hepatitis C or poisoning, e.g., with polyhalogenated aromatic compounds such as hexachlorobenzene. Signs and symptoms are blisters, skin fragility, erosions hyperpigmentation, sclerodermoid plaques. Therapy includes sun protection, prevention of risk factors, phlebotomy, and chloroquine.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Skin aging is determined by a combination of endogenous and environmental influences, including epigenetic, posttranslational, microbial, and lifestyle factors. In particular genetic changes, programmed or not, play a pivotal role and understanding of these complex mechanisms may contribute to the prevention of age-related diseases and extension of healthy lifespan. In this article, new knowledge about genes and biological processes that can significantly affect skin homeostasis in old age and can lead to the typical morphological and physiological characteristics of aging skin are summarized.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Porphyrias comprise a heterogeneous group of predominantly genetically determined metabolic diseases which are due to a dysfunction in heme biosynthesis. Variegate porphyria and hereditary coproporphyria are referred to as neurocutaneous porphyrias because affected patients can develop both cutaneous symptoms on light-exposed body sites and potentially life-threatening acute neurovisceral symptoms, thereby mimicking several other diseases. In this overview, we provide an update on pathogenesis, clinical manifestation, diagnosis, and therapy of these two types of porphyria.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Restoration of tissue integrity is essential for host defense and protection of the organism. The efficacy and quality of skin repair varies significantly over a person’s lifetime. Whereas prenatal wound healing is characterized by regeneration and scarless healing, scarring, fibrosis, and loss of function are features of postnatal repair. In fact, aging is the prominent risk factor for chronic wounds, skin fragility, infections, comorbidities, and decreased quality of life. Current strategies for restoration of tissue integrity and wound therapy are not sufficient and require further investigation of the underlying pathomechanisms and the development of causal-based concepts.
    No preview · Article · Jan 2016 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rosacea is a common chronic inflammatory disease, especially in patients with fair skin and positive family history. Typical locations are forehead, nose, cheeks and chin; the periorbital region is usually not involved. Clinical features can be very heterogeneous. Besides different subtypes (erythematotelangiectatic rosacea, papulopustular rosacea, phymatous rosacea), which often overlap, various special forms of rosacea exist. Up to 60 % of patients with cutaneous rosacea suffer from ocular rosacea. In Germany, brimonidine, metronidazol, azelaic acid, and ivermectin are approved for topical therapy of rosacea; for systemic therapy, doxycycline at a subantimicrobial dose (40 mg/day) is the only approved substance. In case of resistance to this therapy, contraindications or side effects, various alternative therapies are available, however off-label.
    No preview · Article · Dec 2015 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epithelial senescence is a complex process depending on intrinsic as well as extrinsic factors (e.g., UV or IR light, tobacco smoke) and must be seen in the context of the aging process especially of the corium and the subcutis. Morphological alterations become apparent in the form of epithelial atrophy, structural changes within the basal membrane, and a decrease in cell count of melanocytes and Langerhans cells. Signs of cellular senescence are reduced proliferation of keratinocytes, cumulation of dysplastic keratinocytes, various mutations (e.g., c-Fos/c-Jun, STAT3, FoxO1), as well as multiple lipid or amino acid metabolic aberrations (e.g., production of advanced glycation endproducts). This causes functional changes within the physical (lipid deficiency, water distribution dysfunction, lack of hygroscopic substances), chemical (pH conditions, oxygen radicals), and immunological barrier. Prophylactically, barrier-protective care products, antioxidant substances (e.g., vitamin C, B3, E, polyphenols, flavonoids), sunscreen products/measurements, and retinoids are used. For correcting alterations in aged epidermis, chemical peelings (fruit acids, β-hydroxy acid, trichloroacetic acid, phenolic compounds), non-ablative (IPL, PDL, Nd:YAG) as well as ablative (CO2, Erbium-YAG) light-assisted methods are used.
    No preview · Article · Dec 2015 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: We present a case of primary systemic anaplastic large-cell lymphoma, which manifested itself through skin involvement in a 32-year-old man. Only the third histological investigation with immunophenotyping resulted in the correct diagnosis of CD30(+) ALK(+) anaplastic large cell lymphoma. After combined chemotherapy and adjuvant radiotherapy, complete remission of the disease was achieved and one year after completion of therapy no relapse occurred. The diagnostic pitfalls and therapeutic options are discussed.
    No preview · Article · Nov 2015 · Der Hautarzt

  • No preview · Article · Nov 2015 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bullous autoimmune diseases are organ-specific disorders characterized by an autoantibody-mediated blistering of skin and mucous membranes. The detection of tissue-bound and serum autoantibodies is prerequisite for the diagnosis of autoimmune blistering diseases. The individual entities of this group may be difficult to differentiate on clinical grounds alone. An accurate diagnosis is however important for prognosis and therapy. A preliminary diagnostic step includes direct and indirect immunofluorescence microscopy, which provide information about the binding pattern and isotype of autoantibodies and allow the diagnosis of the autoimmune blistering disease. Subsequent characterization of the molecular specificity of autoantibodies is necessary for the exact classification of autoimmune bullous dermatoses. The quantitative measurement of autoantibodies against structural proteins of the skin may be often used to assess disease severity at follow-up.
    No preview · Article · Nov 2015 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Case reports We present two patients who were referred to us from other hospitals for further therapy as metastasized occult melanoma patients with extensive stage III and stage IV disease, respectively. On thorough clinical examination, we found a slightly thickened nail plate on the right thumb with barely visible pigmentation and a tiny skin-colored tumor at the proximal nail fold of a 60-year-old man. In a 60-year-old woman, we saw an anatomically almost hidden small nonpigmented tumor on the labia majora close to the posterior commissure. The patients were histologically diagnosed with an ulcerated acrolentigineous melanoma and a nodular mucosal melanoma, respectively. Conclusion With these two case reports we want to emphasize that although extensive radiographic and invasive diagnostic procedures to detect a primary in patients with suspected melanoma of unknown primary are no longer recommended by current guidelines, repeated and thorough clinical examinations can sometimes revise the diagnosis metastasized “occult” melanoma.
    No preview · Article · Nov 2015 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Melanoma therapy has undergone a paradigm shift. Classic chemotherapies with poor treatment responses have been replaced by modern immune checkpoint blockades and targeted therapies with excellent responses. The latter require precise diagnosis of mutations in the melanoma genome as molecular targets for the small molecules. The diagnosis of melanomas has also been supplemented by molecular techniques. Differential diagnosis of melanoma and melanoma simulators such as atypical Spitz nevi can be supported by fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH). Here we review the indications and methods for molecular diagnosis of melanocytic tumors.
    No preview · Article · Nov 2015 · Der Hautarzt
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cutaneous dipththeria is an infectious bacterial disease endemic in tropical regions, but rarely diagnosed in Germany. Following travel in Sri Lanka, a 60-year-old German presented to our dermatological clinic with a skin ulcer and extensive erythematous erosive edema of his left foot. Corynebacterium diphtheriae was isolated from a swab of the lesion. There were no clinical signs of toxic diphtheria. The patient was treated with penicillin G and erythromycin, followed by a slow healing of the lesion. The isolated strain could be identified as toxigenic C. diphtheriae mitis. Due to increased travel activity, dermatologists should have uncommon infections like cutaneous diphtheria in mind.
    No preview · Article · Nov 2015 · Der Hautarzt